MP-601205

N/A

Report date: 2023/02/12 00:15:12

NME

Base Information

Drug NameMP-601205

Drug Alias NameMPI-601205MP 601205MPI-601 205

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMembrane proteins inhibitors

TargetsMembrane proteins

Therapy Area/IndicationsCystic Fibrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAptalis Pharma

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAptalis Pharma

Active IndicationsN/A

Inactive IndicationsCystic Fibrosis

ATC CodeN/A